InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Glanzman Robert, Directeur Médical. Director active across 1 company, notably Clene Inc.. Aggregated, 2 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €9k. Activity tracked since 30 June 2021. The latest transaction was filed on 16 May 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Glanzman Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
4,717 股@ US$2.03100.0% 占其流量Common StockSEC:0001562180-22-004174:0
15,281 股0Common StockSEC:0001562180-21-004607:0
2 条申报中的 2 条
About Glanzman Robert
Glanzman Robert serves as Chief Medical Officer at Clene Inc. In this role, he is responsible for the company's medical strategy and research initiatives. His expertise in the medical field enables him to lead teams in developing new treatments. He plays a crucial role in guiding Clene's research and development efforts.
